← FDA Drug Approvals (Drugs@FDA)
DOXEPIN HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS · Approved 2023-02-17
Drug application
- FDA Application #
ANDA215408- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DOXEPIN HYDROCHLORIDE
- Generic name
- DOXEPIN HYDROCHLORIDE
- Active ingredients
- DOXEPIN HYDROCHLORIDE
- Dosage form
- CREAM
- Route
- TOPICAL
- Marketing status
- Prescription
- Sponsor
- TEVA PHARMS
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- First approval
- 2023-02-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown